Researchers from Heidelberg University Hospital and the University of Lucerne as well as international scientists, patient representatives and European cancer societies have pooled scientific data and ...

After an average of 44 months (with a range of 26-62 months), the rate of cancer recurrence in the axillary nodes was 2.9% in the 103 patients who received radiation alone with no further lymph node ...

Applies to most patients with one or two positive sentinel lymph nodes ...

Trends and outcomes in patients receiving neoadjuvant chemotherapy for breast cancer in Ontario: A population-based study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...

Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...

Neoadjuvant chemotherapy (NAC) is one of the standard-of-care therapies for breast cancer (BC) with axillary lymph node (ALN) metastases. However, the response to this therapy varies depending on the ...

An international team of researchers has identified several risk factors for persistent pain after breast cancer surgery; these include younger age, radiation therapy and removal of lymph nodes under ...

Advances in cancer treatment mean more people are living longer after a cancer diagnosis. But some survivors develop lymphedema—long-term swelling in the arms, hands, legs or feet that can cause pain, ...

Clinical relevance of the use of FDG PET/CT in locally advanced breast cancer. This is an ASCO Meeting Abstract from the 2012 Breast Cancer Symposium. This abstract does not include a full text ...

Milan, Italy: Patients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid extensive removal of the lymph nodes if their treatment is tailored to their ...

Thousands of women could now be spared one of the most debilitating side-effects of breast cancer treatment - lifelong ...